Cyclerion Therapeutics Inc. (NASDAQ: CYCN)
$3.29
+0.3700 ( +12.67% ) 1.8K
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
Market Data
Open
$3.29
Previous close
$2.92
Volume
1.8K
Market cap
$7.37M
Day range
$2.79 - $3.18
52 week range
$1.75 - $5.25
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Oct 23, 2023 |
4 | Insider transactions | 1 | Aug 11, 2023 |
10-q | Quarterly Reports | 62 | Jul 28, 2023 |
8-k | 8K-related | 12 | Jul 19, 2023 |
8-k | 8K-related | 12 | Jul 12, 2023 |